Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLi, Kenny-
dc.contributor.authorBarras, Christen D-
dc.contributor.authorChandra, Ronil V-
dc.contributor.authorKok, Hong Kuan-
dc.contributor.authorMaingard, Julian T-
dc.contributor.authorCarter, Nicole S-
dc.contributor.authorRussell, Jeremy H-
dc.contributor.authorLai, Leon-
dc.contributor.authorBrooks, Duncan Mark-
dc.contributor.authorAsadi, Hamed-
dc.identifier.citationWorld Neurosurgery 2019; 126: 513-527en
dc.description.abstractDespite decades of research, cerebral vasospasm (CV) continues to account for high morbidity and mortality in patients who survive their initial aneurysm subarachnoid haemorrhage (aSAH). To define the scope of the problem and review key treatment strategies that have shaped the way cerebral vasospasm is managed in the contemporary era. A literature search of cerebral vasospasm management after aneurysmal subarachnoid haemorrhage was performed. Recent advances in neuroimaging have led to an improved detection of vasospasm, but established treatment guidelines including haemodynamic augmentation and interventional procedures remain highly variable among neurosurgical centres. Experimental research in SAH continues to identify novel targets for therapy. Proactive and preventative strategies such as oral nimodipine and endovascular rescue therapies can reduce the morbidity and mortality associated with CV.en
dc.subjectAneurysmal subarachnoid haemorrhageen
dc.subjectdelayed cerebral ischaemiaen
dc.subjectdelayed ischaemic neurologic deficitsen
dc.subjectintra-arterial vasodilatoren
dc.subjecttransluminal balloon angioplastyen
dc.titleA review on the management of cerebral vasospasm following aneurysmal subarachnoid haemorrhage.en
dc.typeJournal Articleen
dc.identifier.journaltitleWorld Neurosurgeryen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental health, 30 Royal Parade, Parkville, Victoria, 3052, Australiaen
dc.identifier.affiliationDepartment of Neurosurgery, Monash Health, 249 Clayton Road, Clayton, Victoria, 3168, Australiaen
dc.identifier.affiliationDepartment of Neurosurgery, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationFaculty of Medicine, Nursing and Health Sciences, Monash University, Level 5, 35 Rainforest Walk, Clayton, Victoria 3800, Australiaen
dc.identifier.affiliationInterventional Radiology Service, Northern Health, 185 Cooper Street, Epping, Victoria 3076, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Service, Monash Health, 249 Clayton Road, Clayton, Victoria, 3168, Australiaen
dc.identifier.affiliationThe South Australian Health and Medical Research Institute, North Terrace, Adelaide, South Australia 5000, Australiaen
dc.identifier.affiliationInterventional Radiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationUniversity of Adelaide, Level 3, Helen Mayo North, Frome Road, North Terrace Campus, Adelaide, South Australia 5005, Australiaen
dc.identifier.affiliationSchool of Medicine - Faculty of Health, Deakin University, 75 Pigdons Road, Geelong, Victoria 3216, Australiaen
dc.type.austinJournal Article-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jun 6, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.